nanotech
Cancer Research UK Announces Nanotech Breakthrough
Filed in archive Research by jeff goldman on March 13, 2009

Following up on the post below, more nanotech cancer-fighting news: researchers at Cancer Research UK this week announced the development of a treatment "whereby tiny nano particles carried anti-tumor genes into cancer cells and 'zapped' them by causing them to make proteins that killed the cancer," according to Medical News Today's Catharine Paddock.


"Cancer Research UK's andreas Schatzlein, based at the School of Pharmacy in London, said it was the first time that nanoparticles had been shown to target tumors in such a selective way," according to Reuters.


"Once inside the cell, the gene enclosed in the particle recognises the cancerous environment and switches on," Schatzlein says. "The result is toxic, but only to the offending cells, leaving healthy tissue unaffected. We hope this therapy will be used to treat cancer patients in clinical trials in a couple of years."


More here from The Press Association ... more here from BBC News ... more here from Computerworld ... and the press release is here.





Permalink: Cancer Research UK Announces Nanotech Breakthrough
Tags: Cancer  Research  UK  Schatzlein  School  of  Pharmacy  London  nanoparticles  nano  particle  nanotechnology  n 
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/146246
img Addthis img Ask img Blinklist img del.icio.us img Digg img Fark img Facebook img Google img Lycos img Ma.gnolia Add this page to Mister Wong Mr Wong img Netscape img Netvousz img Newsvine img Reddit img StumbleUpon img Slashdot img Tailrank img Technorati img Wink img Yahoo

Vote for Cancer Research UK Announces Nanotech Breakthrough:

  • Currently 8.00/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 8.00 out of 4 vote(s) cast.
 
Subscribe
Share It
RSSrss
See all blog subscribe options
Google google
What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter

TwitterFollow us on Twitter!